Charles River Laboratories International, Inc. (CRL) stock
CRLNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 27
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30225% above fair value
$332.16−3.36 (-1.00%)
Close on Nov 17, 2026Market cap $15.86BP/E –Yield –
Charles River Laboratories International enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Charles River Laboratories International's enterprise value was $18.66B on Nov 11, 2026, against $10.75B a year earlier. Over the last 5 years it ranged from $8.11B to $21.70B, with a median of $13.08B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $18.66B | +58.1% |
| 2025 | Dec 31, 2025 | $11.80B | +2.1% |
| 2024 | Dec 31, 2024 | $11.56B | -20.2% |
| 2023 | Dec 29, 2023 | $14.49B | +4.8% |
| 2022 | Dec 30, 2022 | $13.83B | -36.2% |
| 2021 | Dec 31, 2021 | $21.70B | +52.8% |
| 2020 | Dec 31, 2020 | $14.20B | +54.2% |
| 2019 | Dec 31, 2019 | $9.21B | +32.1% |
| 2018 | Dec 31, 2018 | $6.97B | +12.7% |
| 2017 | Dec 29, 2017 | $6.19B | +30.4% |
| 2016 | Dec 30, 2016 | $4.74B | +5.3% |
| 2015 | Dec 31, 2015 | $4.50B | +24.4% |
| 2014 | Dec 31, 2014 | $3.62B | -99.9% |
| 2013 | Dec 31, 2013 | $2.56T | +106683.4% |
| 2012 | Dec 31, 2012 | $2.40B | +19.1% |
| 2011 | Dec 30, 2011 | $2.01B | -23.4% |
| 2010 | Dec 31, 2010 | $2.63B | – |
See a number that looks wrong?